Preliminary results from a non-inferiority clinical trial evaluating the efficacy of three commercial dry cow mastitis preparations

Authors

  • A. G. Arruda Department of Veterinary Population Medicine, University of Minnesota, St Paul, MN, 55108
  • S. Godden Department of Veterinary Population Medicine, University of Minnesota, St Paul, MN, 55108
  • P. Rapnicki Department of Veterinary Population Medicine, University of Minnesota, St Paul, MN, 55108
  • P. Gorden Veterinary Diagnostic and Production Animal Medicine, University of Iowa, Ames, IA, 50011
  • L. Timms Veterinary Diagnostic and Production Animal Medicine, University of Iowa, Ames, IA, 50011
  • S. Aly Department of Population Health and Reproduction, University of California, Davis, Tulare, CA, 93274
  • T. Lehenbauer Department of Population Health and Reproduction, University of California, Davis, Tulare, CA, 93274
  • J. Champagne Department of Population Health and Reproduction, University of California, Davis, Tulare, CA, 93274

DOI:

https://doi.org/10.21423/aabppro20123900

Keywords:

blanket dry cow therapy, dairy herds, antimicrobial, DCT products, intramammary infections

Abstract

Although the practice of blanket dry cow therapy (DCT) has been widely adopted in North American dairy herds, the efficacy of various antimicrobial formulations was typically established many years ago and studies comparing efficacy among various commercial DCT products are largely lacking. The objectives of this study were to evaluate and compare the 1) ability to cure existing intramammary infections (IMI) present at dry-off, 2) ability to prevent new IMI during the dry period, and 3) overall risk for presence of IMI after calving among three DCT products.

Downloads

Published

2012-09-20

Issue

Section

Research Summaries 1

Most read articles by the same author(s)

1 2 3 4 5 > >>